Require hospitals to provide overdose reversal drugs
Ohio SB 137 requires hospitals to stock and administer overdose reversal drugs like naloxone to patients experiencing opioid overdoses in emergency settings.
Ohio SB 137 requires hospitals to stock and administer overdose reversal drugs like naloxone to patients experiencing opioid overdoses in emergency settings.
SB 137 would mandate that hospitals in Ohio maintain and provide access to overdose reversal medications, primarily naloxone (Narcan), to patients experiencing opioid overdoses. The bill establishes a requirement for hospital emergency departments and other relevant units to stock these life-saving drugs and administer them as part of standard overdose treatment protocols.
Opioid overdose deaths remain a critical public health crisis in Ohio, and rapid access to reversal drugs significantly increases survival rates. Ensuring all hospitals have standardized access to naloxone removes variability in emergency response and could prevent deaths among vulnerable populations. This represents a practical policy intervention with demonstrated effectiveness in reducing overdose mortality.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.